These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36741580)

  • 1. Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m).
    Beversdorf DQ; Anagnostou E; Hardan A; Wang P; Erickson CA; Frazier TW; Veenstra-VanderWeele J
    Front Psychiatry; 2022; 13():1079006. PubMed ID: 36741580
    [No Abstract]   [Full Text] [Related]  

  • 2. The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders.
    Loth E; Charman T; Mason L; Tillmann J; Jones EJH; Wooldridge C; Ahmad J; Auyeung B; Brogna C; Ambrosino S; Banaschewski T; Baron-Cohen S; Baumeister S; Beckmann C; Brammer M; Brandeis D; Bölte S; Bourgeron T; Bours C; de Bruijn Y; Chakrabarti B; Crawley D; Cornelissen I; Acqua FD; Dumas G; Durston S; Ecker C; Faulkner J; Frouin V; Garces P; Goyard D; Hayward H; Ham LM; Hipp J; Holt RJ; Johnson MH; Isaksson J; Kundu P; Lai MC; D'ardhuy XL; Lombardo MV; Lythgoe DJ; Mandl R; Meyer-Lindenberg A; Moessnang C; Mueller N; O'Dwyer L; Oldehinkel M; Oranje B; Pandina G; Persico AM; Ruigrok ANV; Ruggeri B; Sabet J; Sacco R; Cáceres ASJ; Simonoff E; Toro R; Tost H; Waldman J; Williams SCR; Zwiers MP; Spooren W; Murphy DGM; Buitelaar JK
    Mol Autism; 2017; 8():24. PubMed ID: 28649312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification.
    Mesleh AG; Abdulla SA; El-Agnaf O
    J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33450950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in autism spectrum disorder: the old and the new.
    Ruggeri B; Sarkans U; Schumann G; Persico AM
    Psychopharmacology (Berl); 2014 Mar; 231(6):1201-16. PubMed ID: 24096533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.
    Ristori MV; Mortera SL; Marzano V; Guerrera S; Vernocchi P; Ianiro G; Gardini S; Torre G; Valeri G; Vicari S; Gasbarrini A; Putignani L
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise of precision medicine in autism.
    Kostic A; Buxbaum JD
    Neuron; 2021 Jul; 109(14):2212-2215. PubMed ID: 34293291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders.
    Beversdorf DQ;
    J Dev Behav Pediatr; 2016 Oct; 37(8):659-73. PubMed ID: 27676697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain exosomes as minuscule information hub for Autism Spectrum Disorder.
    Dean DD; Agarwal S; Muthuswamy S; Asim A
    Expert Rev Mol Diagn; 2021 Dec; 21(12):1323-1331. PubMed ID: 34720032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the Heterogeneous Cortical Anatomy of Autism Spectrum Disorder Using Normative Models.
    Zabihi M; Oldehinkel M; Wolfers T; Frouin V; Goyard D; Loth E; Charman T; Tillmann J; Banaschewski T; Dumas G; Holt R; Baron-Cohen S; Durston S; Bölte S; Murphy D; Ecker C; Buitelaar JK; Beckmann CF; Marquand AF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jun; 4(6):567-578. PubMed ID: 30799285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annual Research Review: Understudied populations within the autism spectrum - current trends and future directions in neuroimaging research.
    Jack A; A Pelphrey K
    J Child Psychol Psychiatry; 2017 Apr; 58(4):411-435. PubMed ID: 28102566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome, Environment, Microbiome and Metabolome in Autism (GEMMA) Study Design: Biomarkers Identification for Precision Treatment and Primary Prevention of Autism Spectrum Disorders by an Integrated Multi-Omics Systems Biology Approach.
    Troisi J; Autio R; Beopoulos T; Bravaccio C; Carraturo F; Corrivetti G; Cunningham S; Devane S; Fallin D; Fetissov S; Gea M; Giorgi A; Iris F; Joshi L; Kadzielski S; Kraneveld A; Kumar H; Ladd-Acosta C; Leader G; Mannion A; Maximin E; Mezzelani A; Milanesi L; Naudon L; Marzal LNP; Pardo PP; Prince NZ; Rabot S; Roeselers G; Roos C; Roussin L; Scala G; Tuccinardi FP; Fasano A
    Brain Sci; 2020 Oct; 10(10):. PubMed ID: 33081368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of eye-tracking measures of social attention as a potential biomarker for autism clinical trials.
    Murias M; Major S; Davlantis K; Franz L; Harris A; Rardin B; Sabatos-DeVito M; Dawson G
    Autism Res; 2018 Jan; 11(1):166-174. PubMed ID: 29193826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of research on the genetics of autism spectrum disorder: methodological, clinical and conceptual progress.
    Arnett AB; Trinh S; Bernier RA
    Curr Opin Psychol; 2019 Jun; 27():1-5. PubMed ID: 30059871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification.
    McPartland JC; Bernier RA; Jeste SS; Dawson G; Nelson CA; Chawarska K; Earl R; Faja S; Johnson SP; Sikich L; Brandt CA; Dziura JD; Rozenblit L; Hellemann G; Levin AR; Murias M; Naples AJ; Platt ML; Sabatos-DeVito M; Shic F; Senturk D; Sugar CA; Webb SJ;
    Front Integr Neurosci; 2020; 14():16. PubMed ID: 32346363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Search of Biomarkers for Autism Spectrum Disorder.
    Del Valle Rubido M; McCracken JT; Hollander E; Shic F; Noeldeke J; Boak L; Khwaja O; Sadikhov S; Fontoura P; Umbricht D
    Autism Res; 2018 Nov; 11(11):1567-1579. PubMed ID: 30324656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential cytokine biomarkers in autism spectrum disorders.
    Rose D; Ashwood P
    Biomark Med; 2014; 8(9):1171-81. PubMed ID: 25402586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence quantification analysis of resting state EEG signals in autism spectrum disorder - a systematic methodological exploration of technical and demographic confounders in the search for biomarkers.
    Heunis T; Aldrich C; Peters JM; Jeste SS; Sahin M; Scheffer C; de Vries PJ
    BMC Med; 2018 Jul; 16(1):101. PubMed ID: 29961422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in autism.
    Goldani AA; Downs SR; Widjaja F; Lawton B; Hendren RL
    Front Psychiatry; 2014; 5():100. PubMed ID: 25161627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large scale validation of an early-age eye-tracking biomarker of an autism spectrum disorder subtype.
    Wen TH; Cheng A; Andreason C; Zahiri J; Xiao Y; Xu R; Bao B; Courchesne E; Barnes CC; Arias SJ; Pierce K
    Sci Rep; 2022 Mar; 12(1):4253. PubMed ID: 35277549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for a comprehensive molecular characterization of autism spectrum disorders.
    Broek JA; Brombacher E; Stelzhammer V; Guest PC; Rahmoune H; Bahn S
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):651-73. PubMed ID: 24229490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.